Yanaihara Nozomu

Affiliation and department：

Research field (1)： Other

Research theme for competitive and other funds (8)：

2020 - 2023 Application of Artificial Intelligence for Precision Medicine in Ovarian Cancer
2016 - 2019 MicroRNA Gene Expression Signature in Ovarian Cancer
2013 - 2016 Search for the biomarkers for the survival of patients of ovariacn clear cell adenocarcinoma
2013 - 2016 Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary
2008 - 2011 Search for prognosistic factors and biomarkers for the survival of patients with ovarian clear cell carcinoma

Show all

Papers (130)：

Yuki Kochi, Satoshi Hosoya, Nozomu Yanaihara, Chie Nagata, Rie Honda, Miwako Shimazaki, Kota Yokosu, Takafumi Kuroda, Motoaki Saito, Hiroshi Tanabe, et al. Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer. International journal of clinical oncology. 2024
大曽根史将, 齋藤良介, 鈴木瑛太郎, 關壽之, 竹中将貴, 永田知映, 柳田聡, 斎藤元章, 矢内原臨, 高野浩邦, et al. 子宮頸部胃型腺癌の臨床学的特徴. 関東連合産科婦人科学会誌. 2023. 60. 3. 361-361
小山奈那子, 小田嶋俊, 幸地優希, 細谷聡史, 井上こころ, 本多理恵, 横須幸太, 鈴木瑛太郎, 齋藤良介, 黒田高史, et al. 卵巣癌・卵管癌・腹膜癌IIIB/C期の初回再発部位と再発リスク因子の検討. 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2023. 65回. 291-291
Nozomu Yanaihara, Yuki Yoshino, Daito Noguchi, Junya Tabata, Masataka Takenaka, Yasushi Iida, Misato Saito, Satoshi Yanagida, Masami Iwamoto, Takako Kiyokawa, et al. Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway. Gynecologic oncology. 2023. 168. 83-91
細谷聡史, 矢内原臨, 岡本愛光. 【産婦人科における素朴な疑問と解説(2)産科編】子宮頸がん合併妊娠女性は経腟分娩しないほうがいいの?. 産科と婦人科. 2022. 89. 11. 1191-1195

ｍore...

MISC (215)：

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page